"Therapeutic Equivalency" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease.
| Descriptor ID |
D013810
|
| MeSH Number(s) |
G03.787.559 G07.690.725.898
|
| Concept/Terms |
Therapeutic Equivalency- Therapeutic Equivalency
- Clinical Equivalencies
- Equivalencies, Clinical
- Equivalency, Clinical
- Generic Equivalency
- Equivalencies, Generic
- Equivalency, Generic
- Generic Equivalencies
- Equivalencies, Therapeutic
- Therapeutic Equivalencies
- Equivalency, Therapeutic
- Bioequivalence
- Bioequivalences
- Clinical Equivalency
|
Below are MeSH descriptors whose meaning is more general than "Therapeutic Equivalency".
Below are MeSH descriptors whose meaning is more specific than "Therapeutic Equivalency".
This graph shows the total number of publications written about "Therapeutic Equivalency" by people in this website by year, and whether "Therapeutic Equivalency" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 1 | 8 | 9 |
| 2018 | 0 | 8 | 8 |
| 2019 | 0 | 3 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Therapeutic Equivalency" by people in Profiles.
-
Tackling the challenges of nanomedicines: are we ready? Am J Health Syst Pharm. 2021 06 07; 78(12):1047-1056.
-
Bioequivalence study of two favipiravir tablet formulations in healthy male subjects. Int J Clin Pharmacol Ther. 2021 May; 59(5):409-416.
-
A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers. J Pharm Biomed Anal. 2021 May 30; 199:114057.
-
A Novel Clinical Consideration to Conserve Parenteral Fentanyl During the COVID-19 Pandemic. Anesth Analg. 2020 11; 131(5):1355-1357.
-
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries. Am J Cardiovasc Drugs. 2020 Jun; 20(3):259-269.
-
Biosimilars: what the oncologist should know. Future Oncol. 2019 Apr; 15(10):1147-1165.
-
[Generic medicinal products: if you know them, you do not avoid them]. G Ital Cardiol (Rome). 2019 Feb; 20(2):66-72.
-
Bioidentical hormone therapy in menopause: relevance in dermatology. Dermatol Online J. 2019 Jan 15; 25(1).
-
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. J Antimicrob Chemother. 2018 08 01; 73(8):2120-2128.
-
A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab. Br J Clin Pharmacol. 2018 10; 84(10):2336-2343.